Methods |
Women allocated to 3 groups. The method was not reported |
Participants |
120 women attending a family planning clinic, Shenzhen, China |
Interventions |
Mife 25 mg, single dose vs Mife 10 mg, single dose |
Outcomes |
Observed number of pregnancies, side effects and changes in menstrual pattern |
Notes |
Observed pregnancy/total number of women: Mife 25 mg 8/60; Mife 10 mg 7/60
-
Side effects:
Total side effects: Mife 25 mg 11/60; Mife 10 mg 9/60
-
Changes in menstrual pattern:
Early: Mife 25 mg 15/52; Mife 10 mg 15/53
Delay: Mife 25 mg 7/52; Mife 10 mg 8/53
|
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Unclear risk |
Mentioned randomisation but description not adequate |
Allocation concealment (selection bias) |
Unclear risk |
Method of allocation concealment not mentioned |
Blinding (performance bias and detection bias) All outcomes |
Unclear risk |
Not mentioned |
Incomplete outcome data (attrition bias) All outcomes |
Unclear risk |
No mention of post‐randomisation exclusion and loss to follow‐up |
Selective reporting (reporting bias) |
Low risk |
Reported planned outcomes |
Other bias |
Low risk |
None detected |